Cargando…
The teratogenic effects of imatinib mesylate on rat fetuses
Imatinib mesylate, a selective tyrosine kinase inhibitor, is the first line treatment against chronic myelogenous leukemia and gastrointestinal stromal tumors. The aim of the present study is to investigate the effects of imatinib mesylate on the pregnant rats and their fetuses. Pregnant rats were d...
Autores principales: | El Gendy, M.M., Kandil, A.M., Helal, M.A., Zahou, F.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598385/ https://www.ncbi.nlm.nih.gov/pubmed/28962401 http://dx.doi.org/10.1016/j.toxrep.2015.05.001 |
Ejemplares similares
-
A Newborn with Teratogenic Effect of Imatinib Mesylate: A Very Rare Case Report
por: Jain, Namita, et al.
Publicado: (2015) -
Teratogenic Effects of Coadministration of Fluoxetine and Olanzapine on Rat Fetuses
por: Bakhtiarian, Azam, et al.
Publicado: (2014) -
Teratogenic effects of silymarin on mouse fetuses
por: Gholami, Mahbobe, et al.
Publicado: (2016) -
Periorbital edema secondary to imatinib mesylate
por: McClelland, Collin M, et al.
Publicado: (2010) -
Cutaneous adverse effects of imatinib mesylate
por: Dogu, Mehmet Hilmi, et al.
Publicado: (2015)